| Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study DK Nomah, J Reyes-Urueña, Y Díaz, S Moreno, J Aceiton, A Bruguera, ... The Lancet HIV 8 (11), e701-e710, 2021 | 95 | 2021 |
| Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection L Tarancon-Diez, E Rodríguez-Gallego, A Rull, J Peraire, C Viladés, ... EBioMedicine 42, 86-96, 2019 | 66 | 2019 |
| Pharmacogenetics of adverse effects due to antiretroviral drugs F Vidal, F Gutierrez, M Gutierrez, M Olona, V Sanchez, G Mateo, J Peraire, ... AIDS Rev 12 (1), 15-30, 2010 | 64 | 2010 |
| Human immunodeficiency virus/hepatitis C virus coinfection in Spain: prevalence and patient characteristics J Berenguer, A Rivero, I Jarrín, MJ Núñez, MJ Vivancos, M Crespo, ... Open forum infectious diseases 3 (2), ofw059, 2016 | 60 | 2016 |
| Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity? M Saumoy, F Vidal, J Peraire, S Sauleda, AM Vea, C Viladés, E Ribera, ... Aids 18 (12), 1741-1742, 2004 | 59 | 2004 |
| Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort JM Llibre, A Montoliu, JM Miró, P Domingo, M Riera, J Tiraboschi, ... HIV medicine 20 (3), 237-247, 2019 | 49 | 2019 |
| Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study S Serrano-Villar, J Martínez-Sanz, R Ron, A Talavera-Rodríguez, ... The lancet HIV 7 (8), e565-e573, 2020 | 48 | 2020 |
| Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudine V Diaz–Brito, A León, H Knobel, J Peraire, P Domingo, B Clotet, ... Antiviral therapy 17 (2), 337-346, 2012 | 48 | 2012 |
| Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir E Martinez, A Gonzalez‐Cordon, E Ferrer, P Domingo, E Negredo, ... Hiv Medicine 15 (6), 330-338, 2014 | 46 | 2014 |
| Spanish HIV-1-infected long-term nonprogressors of more than 15 years have an increased frequency of the CX3CR1 249I variant allele F Vidal, C Viladés, P Domingo, M Broch, E Pedrol, D Dalmau, H Knobel, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (5), 527-531, 2005 | 43 | 2005 |
| Fatal Listeria meningitis, endocarditis and pericarditis in a patient with haemochromatosis C Manso, I Rivas, J Peraire, F Vidal, C Richart Scandinavian journal of infectious diseases 29 (3), 308-309, 1997 | 43 | 1997 |
| Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy S Veloso, X Escoté, V Ceperuelo-Mallafré, M López-Dupla, J Peraire, ... Cytokine 58 (2), 253-260, 2012 | 38 | 2012 |
| Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: a randomized clinical trial E Martinez, A Gonzalez-Cordon, E Ferrer, P Domingo, E Negredo, ... Clinical Infectious Diseases 60 (5), 811-820, 2015 | 37 | 2015 |
| Effect of TNF-α genetic variants and CCR5Δ32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards S Veloso, M Olona, F García, P Domingo, C Alonso-Villaverde, M Broch, ... BMC medical genetics 11, 1-10, 2010 | 37 | 2010 |
| COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study C Díez, J Del Romero‐Raposo, R Mican, JC López, JR Blanco, ... HIV medicine 22 (9), 867-876, 2021 | 33 | 2021 |
| Adipogenic/lipid, inflammatory, and mitochondrial parameters in subcutaneous adipose tissue of untreated HIV-1–infected long-term nonprogressors: significant alterations … F Vidal, P Domingo, F Villarroya, M Giralt, M López-Dupla, M Gutiérrez, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 61 (2), 131-137, 2012 | 30 | 2012 |
| HIV-1-infected long-term non-progressors have milder mitochondrial impairment and lower mitochondrially-driven apoptosis in peripheral blood mononuclear cells than typical … J Peraire, Ò Miró, M Saumoy, P Domingo, E Pedrol, F Villarroya, ... Current HIV Research 5 (5), 467-473, 2007 | 30 | 2007 |
| Proteomic profile associated with loss of spontaneous human immunodeficiency virus type 1 elite control E Rodríguez-Gallego, L Tarancón-Diez, F García, J Del Romero, ... The Journal of infectious diseases 219 (6), 867-876, 2019 | 29 | 2019 |
| A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients E Rodríguez-Gallego, J Gómez, YM Pacheco, J Peraire, C Viladés, ... Aids 32 (5), 565-573, 2018 | 28 | 2018 |
| Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS) C Viladés, X Escoté, M López-Dupla, E Martinez, P Domingo, V Asensi, ... Journal of Antimicrobial Chemotherapy 69 (6), 1653-1659, 2014 | 28 | 2014 |
